InhaleRx Limited (IRX.AX)
- Previous Close
0.0280 - Open
0.0330 - Bid 0.0320 x --
- Ask 0.0330 x --
- Day's Range
0.0280 - 0.0330 - 52 Week Range
0.0200 - 0.0500 - Volume
127,752 - Avg. Volume
45,329 - Market Cap (intraday)
5.313M - Beta (5Y Monthly) -0.82
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Melbourne, Australia.
inhalerx.com.auRelated News
Performance Overview: IRX.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IRX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IRX.AX
Valuation Measures
Market Cap
5.31M
Enterprise Value
5.16M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
7.98
Enterprise Value/Revenue
207.98
Enterprise Value/EBITDA
-3.59
Financial Highlights
Profitability and Income Statement
Profit Margin
-119.87%
Return on Assets (ttm)
-46.40%
Return on Equity (ttm)
-112.39%
Revenue (ttm)
1.2M
Net Income Avi to Common (ttm)
-1.44M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
715.82k
Total Debt/Equity (mrq)
84.19%
Levered Free Cash Flow (ttm)
-1.59M
Company Insights: IRX.AX
IRX.AX does not have Company Insights